Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

1 Improving the understanding of risk can allow clinicians to better personalize treatment approaches or catch HCC early ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Scientists conducted a simulation study to estimate the impact of cardiovascular-kidney-metabolic (CKM) syndrome on cardiovascular disease (CVD) risk prediction. The study found that adults with ...

A preliminary study combining a patent-applied, AI-powered algorithm with a high-speed, 5-to 30-second video of skin on the face and the palm of the hand detected if someone had high blood pressure as ...

On shorter reports–under five pages–the Table of Content, List of Illustrations, and Executive Summary parts might not be required. Most common is one-inch margins all around. Use your word-processing ...

If you’re living with dementia, participating in a clinical trial may offer you the opportunity to try the latest treatment advances ... has strict sourcing guidelines and relies on peer ...

Opens in a new tab or window An FDA panel on Thursday recommended against sotagliflozin as an adjunct to insulin for patients with type 1 diabetes ... T1D and CKD -- treatment guidelines do ...